All articles tagged with #flumist
The upcoming flu season is expected to be severe, prompting health experts to recommend vaccination for everyone six months and older, with new options like the FluMist nasal spray available for self-administration at home, which is especially appealing to children and athletes due to its pain-free application.
The newly available FluMist Home nasal spray vaccine offers a needle-free, at-home flu vaccination option for children and adults up to age 49, aiming to improve vaccination rates among needle-phobic individuals, with efficacy comparable to traditional flu shots.
US COVID indicators are rising slightly, AstraZeneca launches at-home FluMist, and polio cases increase in four countries, while teen vaccination rates for some vaccines improve but HPV coverage remains stagnant, highlighting ongoing public health efforts and challenges.
FluMist, the FDA-approved nasal spray flu vaccine, is now available for self-administration at home through FluMist Home in 34 states, costing mostly free with insurance and $8.99 for shipping, for individuals aged 2 to 49, with specific safety guidelines and availability restrictions.
AstraZeneca has launched FluMist Home, an at-home delivery service for its nasal spray flu vaccine, approved for self- or caregiver-administration for eligible individuals aged 2-49, aiming to increase vaccination rates and provide a convenient, needle-free option. The vaccine still requires a prescription and is covered by most insurance plans, with shipping costs under $10. It is not suitable for certain populations, including children under 2, pregnant women, and those with specific health conditions.
AstraZeneca's FluMist, a nasal spray flu vaccine, is now available for self-administration at home in 34 US states, aiming to improve vaccination rates by offering a convenient, needle-free option for adults and children, with FDA approval and insurance coverage.